IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,276,834 | +136.4% | 59,308 | +16.8% | 0.00% | – |
| Q2 2023 | $963,259 | +312.2% | 50,778 | +237.0% | 0.00% | – |
| Q1 2023 | $233,673 | -7.3% | 15,066 | +6.1% | 0.00% | – |
| Q4 2022 | $252,033 | +215.0% | 14,199 | 0.0% | 0.00% | – |
| Q3 2022 | $80,000 | -29.2% | 14,199 | -51.1% | 0.00% | – |
| Q2 2022 | $113,000 | -31.1% | 29,059 | -2.6% | 0.00% | – |
| Q1 2022 | $164,000 | -35.2% | 29,834 | +0.5% | 0.00% | – |
| Q4 2021 | $253,000 | +3.7% | 29,693 | +5.8% | 0.00% | – |
| Q3 2021 | $244,000 | +9.9% | 28,056 | +33.7% | 0.00% | – |
| Q2 2021 | $222,000 | -36.8% | 20,985 | -4.0% | 0.00% | – |
| Q1 2021 | $351,000 | +36.0% | 21,849 | +292.9% | 0.00% | – |
| Q4 2020 | $258,000 | +25.2% | 5,561 | -4.7% | 0.00% | – |
| Q3 2020 | $206,000 | +104.0% | 5,833 | +40.6% | 0.00% | – |
| Q2 2020 | $101,000 | – | 4,148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 1,439,544 | $27,308,150 | 8.29% |
| Logos Global Management LP | 2,250,000 | $42,682,500 | 5.80% |
| Deep Track Capital, LP | 5,421,330 | $102,842,630 | 4.76% |
| TCG Crossover Management, LLC | 654,853 | $12,422,561 | 2.04% |
| COMMODORE CAPITAL LP | 900,000 | $17,073,000 | 1.92% |
| ACUTA CAPITAL PARTNERS, LLC | 141,755 | $2,689,092 | 1.82% |
| Affinity Asset Advisors, LLC | 260,000 | $4,932,200 | 1.72% |
| HighVista Strategies LLC | 180,320 | $3,420,670 | 1.56% |
| Redmile Group, LLC | 1,921,152 | $36,444,253 | 1.40% |
| Perceptive Advisors | 2,523,783 | $47,876,164 | 1.39% |